JLL scores FM deal with Bristol-Myers in the USA
Bristol-Myers Squibb (BMS), a global biopharma company, has chosen real estate investment firm, JLL to provide facility management and occupancy planning services for its 10 million-square-foot portfolio in the United States and Puerto Rico.
Under the terms of the deal, JLL will be responsible for delivering industry-leading facilities management services and effective cost management and reporting, across 16 manufacturing, laboratory, R&D and office sites.
Roger Humphrey, executive managing director of JLL’s Life Sciences practice, commented:
“Today’s life sciences companies must maintain a laser focus on operating efficiency and productivity. With our deep life sciences expertise, we will collaborate with BMS to deliver service improvements and innovative facilities management solutions.”
JLL manages more than 100 million square feet of life sciences facilities, including offices, BL-2 and BL-3+ laboratories, clean rooms, vivariums, biorepositories, manufacturing and other technical facilities.
The post JLL scores FM deal with Bristol-Myers in the USA appeared first on FMJ.